A Phase 3 Study in Moderate to Severe Psoriasis Patients

Update Il y a 4 ans
Reference: EUCTR2011-004350-26

Woman and Man

  • | Country :
  • -
  • | organs :
  • -
  • | Specialty :
  • -

Extract

Efficacy of Anti-IL-17 MAb vs. etanercept in subjects with moderate to severe chronic plaque psoriasis based on sPGA and PASI at 12 weeks.


Inclusion criteria

  • Moderate to Severe Plaque Psoriasis